ECM
VIVO

ExodusPoint Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

ExodusPoint Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,725
Closed -$257K – 2760
2020
Q4 		$257K Buy
+13,725
New +$256K ﹤0.01% 1616
2020
Q3 		– Sell
-50,071
Closed -$1.17M – 2369
2020
Q2 		$1.17M Buy
50,071
+35,872
+253% +$520K 0.03% 666
2020
Q1 		$119K Buy
+14,199
New +$120K 0.01% 866

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ExodusPoint Capital Management's VIVO Position: Q1 2021 in Review

ExodusPoint Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2021, closing a stake of 13,725 shares — an estimated $257K sold.

ExodusPoint Capital Management first reported a position in VIVO in Q1 2020 and held it in 3 quarters. The position peaked at $1.17M in Q2 2020. 215 funds tracked by Wall St. Rank hold VIVO as of Q1 2021.

  • ExodusPoint Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 13,725 Meridian Bioscience Inc shares in Q1 2021, an estimated $257K.
  • ExodusPoint Capital Management first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 3 quarters.
  • ExodusPoint Capital Management's Meridian Bioscience Inc position peaked at $1.17M in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.